General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study

被引:20
|
作者
Haastrup, P. F. [1 ]
Rasmussen, S. [1 ]
Hansen, J. M. [2 ]
Christensen, R. D. [1 ]
Sondergaard, J. [1 ]
Jarbol, D. E. [1 ]
机构
[1] Univ Southern Denmark, Dept Publ Hlth, Res Unit Gen Practice, Odense, Denmark
[2] Odense Univ Hosp, Dept Med Gastroenterol, DK-5000 Odense, Denmark
来源
BMC FAMILY PRACTICE | 2016年 / 17卷
关键词
General practice variation; Proton pump inhibitors; Prescribing patterns; QUALITY-OF-CARE; PRACTICE SIZE; CLINICAL-PRACTICE; POPULATION; DISEASE; HEALTH; PRESCRIPTIONS; COMMUNICATION; HYPERTENSION; DEPRIVATION;
D O I
10.1186/s12875-016-0460-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Suggestions of overprescribing of proton pump inhibitors (PPIs) for long-term treatment in primary care have been raised. This study aims to analyse associations between general practice characteristics and initiating long-term treatment with PPIs. Methods: A nationwide register-based cohort study of patients over 18 years redeeming first-time prescription for PPI issued by a general practitioner in Denmark in 2011. Patients redeeming more than 60 defined daily doses (DDDs) of PPI within six months were defined first-time long-term users. Detailed information on diagnoses, concomitant drug use and sociodemography of the cohort was extracted. Practice characteristics such as age and gender of the general practitioner (GP), number of GPs, number of patients per GP, geographical location and training practice status were linked to each PPI user. Logistic regression analysis was used to determine associations between practice characteristics and initiating long-term prescribing of PPIs. Results: We identified 90 556 first-time users of PPI. A total of 30 963 (34.2 %) met criteria for long-term use at six months follow-up. GPs over 65 years had significantly higher odds of long-term prescribing (OR 1.32, CI 1.16-1.50), when compared to younger GPs (< 45 years). Furthermore, female GPs were significantly less likely to prescribe long-term treatment with PPIs (OR 0.87, CI 0.81-0.93) compared to male GPs. Conclusions: Practice characteristics such as GP age and gender could explain some of the observed variation in prescribing patterns for PPIs. This variation may indicate a potential for enhancing rational prescribing of PPIs.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study
    P. F. Haastrup
    S. Rasmussen
    J. M. Hansen
    R. D. Christensen
    J. Søndergaard
    D. E. Jarbøl
    BMC Family Practice, 17
  • [2] Long-term prescribing of proton pump inhibitors in general practice
    Hungin, APS
    Rubin, GP
    O'Flanagan, H
    BRITISH JOURNAL OF GENERAL PRACTICE, 1999, 49 (443) : 451 - 453
  • [3] Long-term Safety Concerns with Proton Pump Inhibitors
    Ali, Tauseef
    Roberts, David Neil
    Tierney, William M.
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (10) : 896 - 903
  • [4] Factors influencing compliance in long-term proton pump inhibitor therapy in general practice
    Hungin, APS
    Rubin, G
    O'Flanagan, H
    BRITISH JOURNAL OF GENERAL PRACTICE, 1999, 49 (443) : 463 - 464
  • [5] Use of proton pump inhibitors and risk of cholangitis: a nationwide cohort study
    Min, Yang Won
    Kang, Danbee
    Shin, Ju-Young
    Kang, Minwoong
    Park, Loo Kyung
    Lee, Kwang Hyuck
    Lee, Jong Kyun
    Lee, Kyu Taek
    Rhee, Poong-Lyul
    Kim, Jae J.
    Guallar, Eliseo
    Cho, Juhee
    Lee, Hyuk
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (07) : 760 - 768
  • [6] Hypomagnesaemia associated with long-term use of proton pump inhibitors
    Toh, James Wei Tatt
    Ong, Evonne
    Wilson, Robert
    GASTROENTEROLOGY REPORT, 2015, 3 (03): : 243 - 253
  • [7] Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study
    Vilmar, Adam
    Dehlendorff, Christian
    Friis, Soren
    Jaattela, Marja
    Tvingsholm, Siri
    Frederiksen, Henrik
    LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1451 - 1457
  • [8] Long-term use of proton pump inhibitors was associated with rapid progression to end stage kidney disease in a Korean nationwide study
    Lee, Yu Jeong
    Kim, Jinmi
    Yu, Dong Han
    Je, Nam Kyung
    Rhee, Harin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [9] Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice
    McGowan, B.
    Bennett, K.
    Barry, M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (07) : 763 - 769
  • [10] The risks of long-term use of proton pump inhibitors: a critical review
    Jaynes, Megan
    Kumar, Avinash B.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2018, 10